Mutations of TPM2 and TPM3 (tropomyosin 3) have been reported to cause various congenital myopathies, such as CAP myopathy, Nemaline myopathy types 1 and 4, and congenital myopathies with fiber-type disproportion [44]. Here, TPM3 is linked to congenital myopathy.